Senti Biosciences Holdings, Inc. (SNTI)
NASDAQ: SNTI · Real-Time Price · USD
0.1813
-0.0357 (-16.45%)
Oct 30, 2026, 12:31 PM EDT - Market open
SNTI Revenue
Senti Biosciences Holdings had revenue of $17.00K in the quarter ending June 30, 2026. This brings the company's total for the last twelve months to $55.00K. In the year 2025, Senti Biosciences Holdings had annual revenue of $22.00K. That makes Senti Biosciences Holdings the 46,486th largest company in the world by revenue and 6,926th in the United States.
Revenue (ttm)
$55.00K
Revenue Growth
n/a
P/S Ratio
122.88
Revenue / Employee
$1,410
Employees
39
Market Cap
5.65M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 22.00K | - | - |
| Dec 31, 2024 | - | - | - |
| Dec 31, 2023 | 2.56M | -1.73M | -40.25% |
| Dec 31, 2022 | 4.29M | 1.53M | 55.23% |
| Dec 31, 2021 | 2.76M | 2.20M | 387.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. It does not take any expenses into account and is therefore different from profits.
SNTI News
- 15 days ago - Senti Biosciences Holdings Transcript: AGM 2026 - Transcripts
- 17 days ago - Senti Biosciences Holdings Proxy statement: Proxy filing - Filings
- 5 weeks ago - Senti Biosciences Holdings Proxy statement: Proxy filing - Filings
- 5 weeks ago - Senti Biosciences Holdings Proxy statement: Proxy filing - Filings
- 5 weeks ago - Senti Biosciences Holdings Registration statement: Registration filing - Filings
- 7 weeks ago - Senti Biosciences Holdings Registration statement: Registration filing - Filings
- 1 month ago - Senti Biosciences Holdings Proxy statement: Proxy filing - Filings
- 1 month ago - Senti Biosciences Holdings Proxy statement: Proxy filing - Filings